Revance Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch RVNC and buy or sell other stocks, ETFs, and their options commission-free!

About RVNC

Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders. 

CEO
Jeffery A. Bedard
CEOJeffery A. Bedard
Employees
597
Employees597
Headquarters
Nashville, Tennessee
HeadquartersNashville, Tennessee
Founded
1999
Founded1999
Employees
597
Employees597

RVNC Key Statistics

Market cap
382.87M
Market cap382.87M
Price-Earnings ratio
-1.90
Price-Earnings ratio-1.90
Dividend yield
—
Dividend yield—
Average volume
697.72K
Average volume697.72K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$7.56
52 Week high$7.56
52 Week low
$2.30
52 Week low$2.30
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.